These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38720269)

  • 1. Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern Myanmar.
    Thu AM; Phyo AP; Pateekhum C; Rae JD; Landier J; Parker DM; Delmas G; Watthanaworawit W; McLean ARD; Arya A; Reyes A; Li X; Miotto O; Soe K; Ashley EA; Dondorp A; White NJ; Day NP; Anderson TJC; Imwong M; Nosten F; Smithuis F
    Malar J; 2024 May; 23(1):138. PubMed ID: 38720269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial.
    McLean ARD; Indrasuta C; Khant ZS; Phyo AK; Maung SM; Heaton J; Aung H; Aung Y; Soe K; Swe MMM; von Seidlein L; Tun NN; Tun KM; Day NPJ; Ashley EA; Hlaing T; Kyaw TT; Dondorp AM; Imwong M; White NJ; Smithuis FM
    Lancet Infect Dis; 2021 Nov; 21(11):1579-1589. PubMed ID: 34147154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum.
    Falq G; Van Den Bergh R; De Smet M; Etienne W; Nguon C; Rekol H; Imwong M; Dondorp A; Kindermans JM
    Malar J; 2016 Sep; 15(1):446. PubMed ID: 27585957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium falciparum Kelch 13 mutations and treatment response in patients in Hpa-Pun District, Northern Kayin State, Myanmar.
    Bonnington CA; Phyo AP; Ashley EA; Imwong M; Sriprawat K; Parker DM; Proux S; White NJ; Nosten F
    Malar J; 2017 Nov; 16(1):480. PubMed ID: 29178921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme.
    Landier J; Parker DM; Thu AM; Lwin KM; Delmas G; Nosten FH;
    Lancet; 2018 May; 391(10133):1916-1926. PubMed ID: 29703425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China-Myanmar border.
    Huang F; Shrestha B; Liu H; Tang LH; Zhou SS; Zhou XN; Takala-Harrison S; Ringwald P; Nyunt MM; Plowe CV
    Malar J; 2020 Sep; 19(1):334. PubMed ID: 32928233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association between the Pfk13 gene mutation and artemisinin resistance phenotype in Plasmodium falciparum isolates from Yunnan Province, China.
    Dong Y; Wang J; Sun A; Deng Y; Chen M; Xu Y; Xue J
    Malar J; 2018 Dec; 17(1):478. PubMed ID: 30563521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular assessment of artemisinin resistance markers, polymorphisms in the k13 propeller, and a multidrug-resistance gene in the eastern and western border areas of Myanmar.
    Nyunt MH; Hlaing T; Oo HW; Tin-Oo LL; Phway HP; Wang B; Zaw NN; Han SS; Tun T; San KK; Kyaw MP; Han ET
    Clin Infect Dis; 2015 Apr; 60(8):1208-15. PubMed ID: 25537878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors.
    Phyo AP; Ashley EA; Anderson TJC; Bozdech Z; Carrara VI; Sriprawat K; Nair S; White MM; Dziekan J; Ling C; Proux S; Konghahong K; Jeeyapant A; Woodrow CJ; Imwong M; McGready R; Lwin KM; Day NPJ; White NJ; Nosten F
    Clin Infect Dis; 2016 Sep; 63(6):784-791. PubMed ID: 27313266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker.
    Tun KM; Imwong M; Lwin KM; Win AA; Hlaing TM; Hlaing T; Lin K; Kyaw MP; Plewes K; Faiz MA; Dhorda M; Cheah PY; Pukrittayakamee S; Ashley EA; Anderson TJ; Nair S; McDew-White M; Flegg JA; Grist EP; Guerin P; Maude RJ; Smithuis F; Dondorp AM; Day NP; Nosten F; White NJ; Woodrow CJ
    Lancet Infect Dis; 2015 Apr; 15(4):415-21. PubMed ID: 25704894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Single Mutation in K13 Predominates in Southern China and Is Associated With Delayed Clearance of Plasmodium falciparum Following Artemisinin Treatment.
    Huang F; Takala-Harrison S; Jacob CG; Liu H; Sun X; Yang H; Nyunt MM; Adams M; Zhou S; Xia Z; Ringwald P; Bustos MD; Tang L; Plowe CV
    J Infect Dis; 2015 Nov; 212(10):1629-35. PubMed ID: 25910630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular surveillance of artemisinin resistance falciparum malaria among migrant goldmine workers in Myanmar.
    Nyunt MH; Wang B; Aye KM; Aye KH; Han JH; Lee SK; Han KT; Htut Y; Han ET
    Malar J; 2017 Mar; 16(1):97. PubMed ID: 28249583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artemisinin resistance-associated markers in Plasmodium falciparum parasites from the China-Myanmar border: predicted structural stability of K13 propeller variants detected in a low-prevalence area.
    He Y; Campino S; Diez Benavente E; Warhurst DC; Beshir KB; Lubis I; Gomes AR; Feng J; Jiazhi W; Sun X; Huang F; Tang LH; Sutherland CJ; Clark TG
    PLoS One; 2019; 14(3):e0213686. PubMed ID: 30883571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial.
    von Seidlein L; Peto TJ; Landier J; Nguyen TN; Tripura R; Phommasone K; Pongvongsa T; Lwin KM; Keereecharoen L; Kajeechiwa L; Thwin MM; Parker DM; Wiladphaingern J; Nosten S; Proux S; Corbel V; Tuong-Vy N; Phuc-Nhi TL; Son DH; Huong-Thu PN; Tuyen NTK; Tien NT; Dong LT; Hue DV; Quang HH; Nguon C; Davoeung C; Rekol H; Adhikari B; Henriques G; Phongmany P; Suangkanarat P; Jeeyapant A; Vihokhern B; van der Pluijm RW; Lubell Y; White LJ; Aguas R; Promnarate C; Sirithiranont P; Malleret B; Rénia L; Onsjö C; Chan XH; Chalk J; Miotto O; Patumrat K; Chotivanich K; Hanboonkunupakarn B; Jittmala P; Kaehler N; Cheah PY; Pell C; Dhorda M; Imwong M; Snounou G; Mukaka M; Peerawaranun P; Lee SJ; Simpson JA; Pukrittayakamee S; Singhasivanon P; Grobusch MP; Cobelens F; Smithuis F; Newton PN; Thwaites GE; Day NPJ; Mayxay M; Hien TT; Nosten FH; Dondorp AM; White NJ
    PLoS Med; 2019 Feb; 16(2):e1002745. PubMed ID: 30768615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.
    Win AA; Imwong M; Kyaw MP; Woodrow CJ; Chotivanich K; Hanboonkunupakarn B; Pukrittayakamee S
    Malar J; 2016 Feb; 15():110. PubMed ID: 26911145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
    Amaratunga C; Lim P; Suon S; Sreng S; Mao S; Sopha C; Sam B; Dek D; Try V; Amato R; Blessborn D; Song L; Tullo GS; Fay MP; Anderson JM; Tarning J; Fairhurst RM
    Lancet Infect Dis; 2016 Mar; 16(3):357-65. PubMed ID: 26774243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluations of candidate markers of dihydroartemisinin-piperaquine resistance in Plasmodium falciparum isolates from the China-Myanmar, Thailand-Myanmar, and Thailand-Cambodia borders.
    Ye R; Zhang Y; Zhang D
    Parasit Vectors; 2022 Apr; 15(1):130. PubMed ID: 35413937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular surveillance of artemisinin resistant falciparum malaria in Myanmar (2009-2013).
    Nyunt MH; Soe MT; Myint HW; Oo HW; Aye MM; Han SS; Zaw NN; Cho C; Aung PZ; Kyaw KT; Aye TT; San NA; Ortega L; Thimasarn K; Bustos MDG; Galit S; Hoque MR; Ringwald P; Han ET; Kyaw MP
    Malar J; 2017 Aug; 16(1):333. PubMed ID: 28806957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance.
    Siddiqui FA; Boonhok R; Cabrera M; Mbenda HGN; Wang M; Min H; Liang X; Qin J; Zhu X; Miao J; Cao Y; Cui L
    mBio; 2020 Feb; 11(1):. PubMed ID: 32098812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy study.
    Tun KM; Jeeyapant A; Imwong M; Thein M; Aung SS; Hlaing TM; Yuentrakul P; Promnarate C; Dhorda M; Woodrow CJ; Dondorp AM; Ashley EA; Smithuis FM; White NJ; Day NP
    Malar J; 2016 Mar; 15():185. PubMed ID: 27036739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.